Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge

被引:61
作者
Shin, Wing Sum [1 ]
Xie, Fuda [1 ,2 ,3 ]
Chen, Bonan [1 ,2 ,3 ]
Yu, Peiyao [4 ]
Yu, Jun [2 ,5 ]
To, Ka Fai [1 ,2 ]
Kang, Wei [1 ,2 ,3 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Translat Oncol, Hong Kong 999077, Peoples R China
[2] Chinese Univ Hong Kong, Inst Digest Dis, State Key Lab Digest Dis, Hong Kong 999077, Peoples R China
[3] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK, Shenzhen 518000, Peoples R China
[4] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Peoples R China
[5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong 999077, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; H; pylori; incidence; mortality; targeted therapy; HELICOBACTER-PYLORI INFECTION; DOUBLE-BLIND; GASTROESOPHAGEAL JUNCTION; OPEN-LABEL; 1ST-LINE THERAPY; RISK-FACTORS; PRECISION MEDICINE; PLUS CHEMOTHERAPY; PHASE-3; ADENOCARCINOMA;
D O I
10.3390/cancers15092639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the decline in incidence and mortality rates, gastric cancer (GC) is the fifth leading cause of cancer deaths worldwide. The incidence and mortality of GC are exceptionally high in Asia due to high H. pylori infection, dietary habits, smoking behaviors, and heavy alcohol consumption. In Asia, males are more susceptible to developing GC than females. Variations in H. pylori strains and prevalence rates may contribute to the differences in incidence and mortality rates across Asian countries. Large-scale H. pylori eradication was one of the effective ways to reduce GC incidences. Treatment methods and clinical trials have evolved, but the 5-year survival rate of advanced GC is still low. Efforts should be put towards large-scale screening and early diagnosis, precision medicine, and deep mechanism studies on the interplay of GC cells and microenvironments for dealing with peritoneal metastasis and prolonging patients' survival.
引用
收藏
页数:22
相关论文
共 145 条
[81]   Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100 [J].
Moehler, Markus ;
Dvorkin, Mikhail ;
Boku, Narikazu ;
Ozguroglu, Mustafa ;
Ryu, Min-Hee ;
Muntean, Alina S. ;
Lonardi, Sara ;
Nechaeva, Marina ;
Bragagnoli, Arinilda C. ;
Coskun, Hasan S. ;
Cubillo Gracian, Antonio ;
Takano, Toshimi ;
Wong, Rachel ;
Safran, Howard ;
Vaccaro, Gina M. ;
Wainberg, Zev A. ;
Silver, Matthew R. ;
Xiong, Huiling ;
Hong, Janet ;
Taieb, Julien ;
Bang, Yung-Jue .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (09) :966-977
[82]   Whole Genome Sequencing Reveals Virulence Potentials ofHelicobacter pyloriStrain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma [J].
Mwangi, Catherine ;
Njoroge, Stephen ;
Tshibangu-Kabamba, Evariste ;
Moloo, Zahir ;
Rajula, Allan ;
Devani, Smita ;
Matsumoto, Takashi ;
Nyerere, Kimang'a ;
Kariuki, Samuel ;
Revathi, Gunturu ;
Yamaoka, Yoshio .
TOXINS, 2020, 12 (09)
[83]   The 2019 WHO classification of tumours of the digestive system [J].
Nagtegaal, Iris D. ;
Odze, Robert D. ;
Klimstra, David ;
Paradis, Valerie ;
Rugge, Massimo ;
Schirmacher, Peter ;
Washington, Kay M. ;
Carneiro, Fatima ;
Cree, Ian A. .
HISTOPATHOLOGY, 2020, 76 (02) :182-188
[84]   Recent advances in gastric cancer early diagnosis [J].
Necula, Laura ;
Matei, Lilia ;
Dragu, Denisa ;
Neagu, Ana, I ;
Mambet, Cristina ;
Nedeianu, Saviana ;
Bleotu, Coralia ;
Diaconu, Carmen C. ;
Chivu-Economescu, Mihaela .
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (17) :2029-2044
[85]   Polymorphism of MUC1 Gene in Vietnamese Gastric Cancer Patients: A Multicenter Case-Control Study [J].
Ngoc-Lan Thi Nguyen ;
Ngoc-Dzung Thi Dang ;
Quang-Huy Dang ;
Van-Chuc Tran ;
Hoang-Long Vo ;
Yamaguchi, Masamitsu ;
Thanh-Van Ta .
FRONTIERS IN ONCOLOGY, 2021, 11
[86]   Vitamin D intake and gastric cancer in Viet Nam: a case-control study [J].
Nguyen, Minh Thien ;
Huynh, Nhi Ngoc Yen ;
Nguyen, Dai Duc ;
Ta, Nguyen Ha ;
Van Nguyen, Tai ;
Dang, Huy Thanh ;
Le, Ngoan Tran .
BMC CANCER, 2022, 22 (01)
[87]   Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study [J].
Ohtsu, Atsushi ;
Ajani, Jaffer A. ;
Bai, Yu-Xian ;
Bang, Yung-Jue ;
Chung, Hyun-Cheol ;
Pan, Hong-Ming ;
Sahmoud, Tarek ;
Shen, Lin ;
Yeh, Kun-Huei ;
Chin, Keisho ;
Muro, Kei ;
Kim, Yeul Hong ;
Ferry, David ;
Tebbutt, Niall C. ;
Al-Batran, Salah-Eddin ;
Smith, Heind ;
Costantini, Chiara ;
Rizvi, Syed ;
Lebwohl, David ;
Van Cutsem, Eric .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) :3935-+
[88]   Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study [J].
Ohtsu, Atsushi ;
Shah, Manish A. ;
Van Cutsem, Eric ;
Rha, Sun Young ;
Sawaki, Akira ;
Park, Sook Ryun ;
Lim, Ho Yeong ;
Yamada, Yasuhide ;
Wu, Jian ;
Langer, Bernd ;
Starnawski, Michal ;
Kang, Yoon-Koo .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) :3968-3976
[89]   Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population [J].
Pan, Kai-Feng ;
Formichella, Luca ;
Zhang, Lian ;
Zhang, Yang ;
Ma, Jun-Ling ;
Li, Zhe-Xuan ;
Liu, Cong ;
Wang, Yu-Mei ;
Goettner, Gereon ;
Ulm, Kurt ;
Classen, Meinhard ;
You, Wei-Cheng ;
Gerhard, Markus .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) :2118-2125
[90]   Dietary intake of walnut prevented Helicobacter pylori-associated gastric cancer through rejuvenation of chronic atrophic gastritis [J].
Park, Jong Min ;
Han, Young Min ;
Park, Yong Jin ;
Hahm, Ki Baik .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2021, 68 (01) :37-50